MENU

Juno Therapeutics Aktie (NASDAQ:JUNO)

Juno is a clinical-stage cell immunotherapy company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.

{{ formattedPrice }} {{ change }} (0 %)

Quotes delayed. Last trade: 01-01-1970, 01:00:00am CET

JUNO vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 0    

Related Articles